| Depression |
1 |
1 |
| Psychotherapy |
0 |
0.99 |
| Antidepressant drug |
0 |
0.98 |
| Hallucinogen |
0 |
0.97 |
| Patient Safety |
0 |
0.26 |
| Addiction |
0 |
0.18 |
| Adverse Effects |
0 |
0.17 |
| Memory |
0 |
0.17 |
| Memory Problems |
0 |
0.16 |
| Brain |
0 |
0.12 |
| Inpatient Care |
0 |
0.12 |
| Major Depression |
0 |
0.12 |
| Meta-Analysis |
0 |
0.12 |
| Pain Management |
0 |
0.12 |
| Psychiatric Emergency |
0 |
0.12 |
| Acute Pain |
0 |
0.06 |
| Analgesia |
0 |
0.06 |
| Anesthesia |
0 |
0.06 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Dopamine |
0 |
0.06 |
| Functional MRI |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Impairment |
0 |
0.06 |
| Intravenous |
0 |
0.06 |
| Lysergic Acid Diethylamide |
0 |
0.06 |
| Methamphetamine |
0 |
0.06 |
| Nausea |
0 |
0.06 |
| Nystagmus |
0 |
0.06 |
| Plasma |
0 |
0.06 |
| Psychology |
0 |
0.06 |
| Psychosomatic Disorder |
0 |
0.06 |
| Psychotropic Drugs |
0 |
0.96 |
| UK Site Content |
0 |
0.06 |